Analysis Article • May 01

Last week, the Clinical Research and Equipment industry hasn't moved much but AddLife is up 5.6% in that time. Unfortunately though, the industry is down 18% over the past 12 months. As for the next few years, earnings are expected to grow by 19% per annum.
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 13 Jun 2026 | SEK 29.9b | SEK 14.6b | -SEK 871,304,353.00 | 34.5x | -34.3x | 2x |
| Mon, 11 May 2026 | SEK 28.5b | SEK 14.6b | -SEK 853,896,077.00 | 33.9x | -33.3x | 1.9x |
| Wed, 08 Apr 2026 | SEK 27.5b | SEK 14.6b | -SEK 971,664,077.00 | 32.2x | -28.3x | 1.9x |
| Fri, 06 Mar 2026 | SEK 27.9b | SEK 14.6b | -SEK 838,374,077.00 | 33.5x | -33.3x | 1.9x |
| Sun, 01 Feb 2026 | SEK 27.3b | SEK 14.9b | -SEK 744,515,427.00 | 42.2x | -36.7x | 1.8x |
| Tue, 30 Dec 2025 | SEK 31.4b | SEK 14.9b | -SEK 744,515,427.00 | 49.5x | -42.1x | 2.1x |
| Thu, 27 Nov 2025 | SEK 34.5b | SEK 14.9b | -SEK 744,515,427.00 | 57.8x | -46.3x | 2.3x |
| Sat, 25 Oct 2025 | SEK 38.2b | SEK 14.7b | SEK 118.3m | 56.2x | 323.2x | 2.6x |
| Mon, 22 Sep 2025 | SEK 36.3b | SEK 14.7b | SEK 61.3m | 56.4x | 592.6x | 2.5x |
| Wed, 20 Aug 2025 | SEK 35.0b | SEK 14.5b | SEK 59.1m | 59.6x | 591.1x | 2.4x |
| Fri, 18 Jul 2025 | SEK 46.2b | SEK 16.7b | SEK 444.3m | 63.6x | 104x | 2.8x |
| Sun, 15 Jun 2025 | SEK 47.0b | SEK 16.6b | SEK 404.2m | 70.6x | 116.4x | 2.8x |
| Tue, 13 May 2025 | SEK 46.7b | SEK 16.6b | SEK 420.1m | 44.4x | 111.2x | 2.8x |
| Thu, 10 Apr 2025 | SEK 33.7b | SEK 16.6b | SEK 609.4m | 35.4x | 55.3x | 2x |
| Sat, 08 Mar 2025 | SEK 38.5b | SEK 16.6b | SEK 614.9m | 39.2x | 62.5x | 2.3x |
| Mon, 03 Feb 2025 | SEK 41.3b | SEK 16.8b | -SEK 1,173,511,426.00 | 44.2x | -35.2x | 2.5x |
| Wed, 01 Jan 2025 | SEK 43.6b | SEK 16.7b | -SEK 1,152,911,426.00 | 50.1x | -37.8x | 2.6x |
| Fri, 29 Nov 2024 | SEK 41.6b | SEK 16.7b | -SEK 1,154,323,426.00 | 47.3x | -36.1x | 2.5x |
| Sun, 27 Oct 2024 | SEK 43.0b | SEK 16.8b | -SEK 956,465,491.00 | 50.1x | -45x | 2.6x |
| Tue, 24 Sep 2024 | SEK 47.1b | SEK 16.7b | -SEK 988,175,491.00 | 57.5x | -47.7x | 2.8x |
| Thu, 22 Aug 2024 | SEK 48.2b | SEK 16.6b | -SEK 317,901,538.00 | 61.6x | -151.6x | 2.9x |
| Sat, 20 Jul 2024 | SEK 48.6b | SEK 16.6b | -SEK 1,138,220,510.00 | 61.7x | -42.7x | 2.9x |
| Mon, 17 Jun 2024 | SEK 43.1b | SEK 16.3b | -SEK 1,188,686,510.00 | 58.1x | -36.2x | 2.6x |
| Wed, 15 May 2024 | SEK 40.6b | SEK 16.3b | -SEK 1,157,635,671.00 | 35.5x | -35.1x | 2.5x |
| Fri, 12 Apr 2024 | SEK 39.5b | SEK 16.0b | -SEK 1,122,792,213.00 | 35.4x | -35.2x | 2.5x |
| Sun, 10 Mar 2024 | SEK 39.7b | SEK 16.0b | -SEK 1,123,139,210.00 | 40.2x | -35.3x | 2.5x |
| Tue, 06 Feb 2024 | SEK 39.0b | SEK 15.8b | -SEK 1,473,823,683.00 | 54.3x | -26.4x | 2.5x |
| Thu, 04 Jan 2024 | SEK 36.5b | SEK 15.5b | -SEK 1,393,723,683.00 | 43.4x | -26.2x | 2.4x |
| Sat, 02 Dec 2023 | SEK 34.6b | SEK 15.5b | -SEK 1,393,723,683.00 | 40.6x | -24.8x | 2.2x |
| Mon, 30 Oct 2023 | SEK 27.1b | SEK 15.4b | -SEK 1,255,923,711.00 | 32x | -21.6x | 1.8x |
| Wed, 27 Sep 2023 | SEK 26.1b | SEK 15.1b | -SEK 1,134,516,711.00 | 38.7x | -23x | 1.7x |
| Fri, 25 Aug 2023 | SEK 29.9b | SEK 15.0b | -SEK 1,155,464,038.00 | 41x | -25.9x | 2x |
| Sun, 23 Jul 2023 | SEK 32.2b | SEK 14.9b | -SEK 239,671,038.00 | 47.8x | -134.4x | 2.2x |
| Tue, 20 Jun 2023 | SEK 37.5b | SEK 14.6b | -SEK 172,476,038.00 | 38.7x | -217.2x | 2.6x |
-217.2x
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | 0.29% | |
| Healthcare | -0.084% | |
| Life Sciences | 2.53% | |
| Clinical Research and Equipment | 2.53% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALIF B AddLife | SEK 160.80 | 5.6% +SEK 1.0b | -19.0% | PE34.5x |